Date Filed | Type | Description |
08/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/11/2022 |
4
| Kutok Jeffery (Chief Scientific Officer) has filed a Form 4 on Epizyme, Inc.
Txns:
| Paid exercise price by delivering 354,496 shares
@ $1.39, valued at
$492.7k
Exercised 380,000 options to buy
@ $1.39, valued at
$528.2k
|
|
04/13/2022 |
4
| Kutok Jeffery (Chief Scientific Officer) has filed a Form 4 on Epizyme, Inc.
Txns:
| Sold 2,741 shares
@ $0.9, valued at
$2.5k
|
|
03/21/2022 |
4
| Kutok Jeffery (Chief Scientific Officer) has filed a Form 4 on Epizyme, Inc.
Txns:
| Granted 380,000 options to buy
@ $1.39, valued at
$528.2k
|
|
02/04/2022 |
4
| Kutok Jeffery (Chief Scientific Officer) has filed a Form 4 on Epizyme, Inc.
Txns:
| Sold 2,556 shares
@ $1.37, valued at
$3.5k
|
|
08/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/03/2020 |
4
| Kutok Jeffery (Chief Scientific Officer) has filed a Form 4 on Epizyme, Inc.
Txns:
| Granted 27,412 shares
@ $0 Granted 131,580 options to buy
@ $13.68, valued at
$1.8M
|
|
04/03/2020 |
3
| Kutok Jeffery (Chief Scientific Officer) has filed a Form 3 on Epizyme, Inc. |
01/13/2020 |
4
| Kutok Jeffery (Chief Scientific Officer) has filed a Form 4 on INFINITY PHARMACEUTICALS, INC.
Txns:
| Granted 64,219 shares
@ $0 Granted 450,000 options to buy
@ $1.25, valued at
$562.5k
|
|
01/07/2019 |
4
| Kutok Jeffery (Chief Scientific Officer) has filed a Form 4 on INFINITY PHARMACEUTICALS, INC.
Txns:
| Granted 155,000 options to buy
@ $1.24, valued at
$192.2k
|
|
08/17/2018 |
4
| Kutok Jeffery (Chief Scientific Officer) has filed a Form 4 on INFINITY PHARMACEUTICALS, INC.
Txns:
| Sold 8,180 shares
@ $2.0074, valued at
$16.4k
Sold 6,133 shares
@ $2, valued at
$12.3k
|
|
06/25/2018 |
4
| Kutok Jeffery (Chief Scientific Officer) has filed a Form 4 on INFINITY PHARMACEUTICALS, INC.
Txns:
| Sold 14,313 shares
@ $2.0048, valued at
$28.7k
|
|
01/04/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/26/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
02/14/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
02/14/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities |